Revenues Not Telling The Story For Guardian Pharmacy Services, Inc. (NYSE:GRDN) After Shares Rise 25%
Aug 20
Have your own idea? Try our Stock Screener
U.S. Drug Retail Industry Analysis
UpdatedSep 25, 2025
DataAggregated Company Financials
Companies11
- 7D-3.5%
- 3M20.1%
- 1Y-19.5%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 3.5%, driven by a pullback from Guardian Pharmacy Services of 3.5%. On the other hand Mangoceuticals is actually up 9.5%. Overall the industry is down 20% in 12 months. As for the next few years, earnings are expected to grow by 85% per annum.
Industry Valuation and Performance
Has the U.S. Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Sep 2025 | US$1.7b | US$3.5b | -US$120,225,568.06 | 20.7x | -14.3x | 0.5x |
| Sat, 23 Aug 2025 | US$12.3b | US$158.1b | -US$6,417,405,738.60 | 18.9x | -1.9x | 0.08x |
| Mon, 21 Jul 2025 | US$11.4b | US$158.1b | -US$6,426,925,786.58 | 33.4x | -1.8x | 0.07x |
| Wed, 18 Jun 2025 | US$11.3b | US$155.4b | -US$5,907,834,093.05 | n/a | -1.9x | 0.07x |
| Fri, 16 May 2025 | US$11.3b | US$155.4b | -US$5,903,992,442.59 | n/a | -1.9x | 0.07x |
| Sun, 13 Apr 2025 | US$10.9b | US$155.3b | -US$5,913,777,072.93 | n/a | -1.8x | 0.07x |
| Tue, 11 Mar 2025 | US$11.1b | US$153.8b | -US$8,983,680,125.87 | n/a | -1.2x | 0.07x |
| Thu, 06 Feb 2025 | US$10.1b | US$153.8b | -US$8,983,614,366.62 | n/a | -1.1x | 0.07x |
| Sat, 04 Jan 2025 | US$9.3b | US$151.0b | -US$8,784,036,651.31 | n/a | -1.1x | 0.06x |
| Mon, 02 Dec 2024 | US$9.5b | US$151.0b | -US$8,784,407,421.88 | n/a | -1.1x | 0.06x |
| Wed, 30 Oct 2024 | US$9.4b | US$151.0b | -US$8,683,587,875.94 | 80.5x | -1.1x | 0.06x |
| Fri, 27 Sep 2024 | US$8.1b | US$149.0b | -US$5,878,918,413.68 | 68.9x | -1.4x | 0.05x |
| Sun, 25 Aug 2024 | US$9.0b | US$147.8b | -US$5,898,367,530.75 | n/a | -1.5x | 0.06x |
| Tue, 23 Jul 2024 | US$9.6b | US$147.8b | -US$5,905,437,044.01 | n/a | -1.6x | 0.07x |
| Thu, 20 Jun 2024 | US$14.0b | US$146.9b | -US$6,131,613,661.55 | n/a | -2.3x | 0.1x |
| Sat, 18 May 2024 | US$16.0b | US$146.9b | -US$6,133,384,607.14 | 38.5x | -2.6x | 0.1x |
| Mon, 15 Apr 2024 | US$15.6b | US$146.9b | -US$6,142,346,623.85 | 44x | -2.5x | 0.1x |
| Wed, 13 Mar 2024 | US$18.8b | US$144.7b | US$499.4m | 32x | 37.6x | 0.1x |
| Fri, 09 Feb 2024 | US$19.9b | US$144.7b | US$499.5m | 34.6x | 39.8x | 0.1x |
| Sun, 07 Jan 2024 | US$21.8b | US$144.8b | US$444.8m | 37.6x | 49x | 0.2x |
| Tue, 05 Dec 2023 | US$18.2b | US$141.4b | -US$3,209,398,303.00 | 45.3x | -5.7x | 0.1x |
| Thu, 02 Nov 2023 | US$18.5b | US$164.8b | -US$4,853,410,231.00 | 67.3x | -3.8x | 0.1x |
| Sat, 30 Sep 2023 | US$18.4b | US$138.4b | -US$3,448,548,996.00 | 361.3x | -5.3x | 0.1x |
| Mon, 28 Aug 2023 | US$22.2b | US$138.4b | -US$3,448,615,016.00 | 361.3x | -6.4x | 0.2x |
| Wed, 26 Jul 2023 | US$26.9b | US$138.4b | -US$3,449,131,262.00 | 361.3x | -7.8x | 0.2x |
| Fri, 23 Jun 2023 | US$27.6b | US$135.5b | -US$3,277,994,699.00 | n/a | -8.4x | 0.2x |
| Sun, 21 May 2023 | US$27.3b | US$135.5b | -US$3,274,079,234.00 | n/a | -8.3x | 0.2x |
| Tue, 18 Apr 2023 | US$31.3b | US$135.5b | -US$3,265,150,677.00 | n/a | -9.6x | 0.2x |
| Thu, 16 Mar 2023 | US$29.2b | US$134.2b | -US$3,076,275,944.00 | n/a | -9.5x | 0.2x |
| Sat, 11 Feb 2023 | US$31.8b | US$134.3b | -US$3,077,143,632.00 | n/a | -10.3x | 0.2x |
| Mon, 09 Jan 2023 | US$31.9b | US$134.3b | -US$3,076,880,521.00 | n/a | -10.4x | 0.2x |
| Wed, 07 Dec 2022 | US$35.4b | US$134.7b | US$4.2b | 8.1x | 8.4x | 0.3x |
| Fri, 04 Nov 2022 | US$31.3b | US$134.7b | US$4.2b | 7.1x | 7.4x | 0.2x |
| Sun, 02 Oct 2022 | US$27.4b | US$136.5b | US$5.0b | 5.3x | 5.5x | 0.2x |
Price to Earnings Ratio
5.5x
Current Industry PE
- Investors are optimistic on the American Drug Retail industry, and appear confident in long term growth rates.
- The industry is trading close to its 3-year average PS ratio of 0.14x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 71% per year, which is driving profits down.
Industry Comparison
How does U.S. Drug Retail compare with similar industries?
| US Market | 0.26% | |
| Consumer Staples | -1.82% | |
| Food and Staples Retail | -1.74% | |
| Drug Retail | -3.54% | |
| Big Box Super Stores | -1.61% | |
| Food Distributors | -2.17% | |
| Food Retail | -2.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MGRX Mangoceuticals | US$2.43 | 9.5% +US$2.4m | -31.1% | PS53x | |
| SRXH SRx Health Solutions | US$0.35 | 1.2% +US$132.8k | n/a | n/a |